tetano
Editor, Senior Moderator
Egypt J Neurol Psychiatr Neurosurg
. 2021;57(1):178.
doi: 10.1186/s41983-021-00435-9. Epub 2021 Dec 20.
Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample
Haidy Elshebawy[SUP] 1 [/SUP], Mohamed Y Ezzeldin[SUP] 2 [/SUP], Eman Hassan Elzamarany[SUP] 3 [/SUP]
Affiliations
Abstract
Background: The aim of this study is to describe the different forms of polyneuropathy associated with coronavirus disease 2019 (COVID-19) as a secondary neurological complication for (COVID-19) and the outcome from different therapeutic regimens in adults and pediatrics in first and second waves of the pandemic.
Case presentation: This study was conducted on 42 patients, they were divided into two groups, group (A) and group (B) in first and second waves respectively. Twenty-five patients presented by ascending weakness preceded by fever, dry cough and respiratory distress, electromyography (EMG) and nerve conduction (NC) studies done and confirmed the clinical diagnosis of demyelinating polyneuropathy. Eight patients presented by acute flaccid quadriparesis, more severe in upper limbs preceded by fever and diarrhea diagnosed as acute axonal polyneuropathy. Five patients presented by severe fatigue and progressive weakness of both lower and upper limbs, they developed fever and cough 10 days after the neurological symptoms. EMG and NC done and confirmed clinical diagnosis of polyneuropathy of demyelinating with secondary axonal picture. Four patients presented 30 to 40 days after their recovery form corona virus infection with gradual progressive weakness of both upper and lower limbs over 2 to 3 months duration, mainly the proximal muscles of lower limbs were affected with areflexia. EMG and NC done and confirmed the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP).
Conclusion: We should gain a better understanding of the underlying pathophysiology and therapeutic options of polyneuropathies related to COVID-19, which will have an impact on the treatment of the COVID related respiratory failure presenting with neuropathy.
Keywords: Adults; Pediatrics; Polyneuropathies; Post COVID.
. 2021;57(1):178.
doi: 10.1186/s41983-021-00435-9. Epub 2021 Dec 20.
Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample
Haidy Elshebawy[SUP] 1 [/SUP], Mohamed Y Ezzeldin[SUP] 2 [/SUP], Eman Hassan Elzamarany[SUP] 3 [/SUP]
Affiliations
- PMID: 34955631
- PMCID: PMC8685814
- DOI: 10.1186/s41983-021-00435-9
Abstract
Background: The aim of this study is to describe the different forms of polyneuropathy associated with coronavirus disease 2019 (COVID-19) as a secondary neurological complication for (COVID-19) and the outcome from different therapeutic regimens in adults and pediatrics in first and second waves of the pandemic.
Case presentation: This study was conducted on 42 patients, they were divided into two groups, group (A) and group (B) in first and second waves respectively. Twenty-five patients presented by ascending weakness preceded by fever, dry cough and respiratory distress, electromyography (EMG) and nerve conduction (NC) studies done and confirmed the clinical diagnosis of demyelinating polyneuropathy. Eight patients presented by acute flaccid quadriparesis, more severe in upper limbs preceded by fever and diarrhea diagnosed as acute axonal polyneuropathy. Five patients presented by severe fatigue and progressive weakness of both lower and upper limbs, they developed fever and cough 10 days after the neurological symptoms. EMG and NC done and confirmed clinical diagnosis of polyneuropathy of demyelinating with secondary axonal picture. Four patients presented 30 to 40 days after their recovery form corona virus infection with gradual progressive weakness of both upper and lower limbs over 2 to 3 months duration, mainly the proximal muscles of lower limbs were affected with areflexia. EMG and NC done and confirmed the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP).
Conclusion: We should gain a better understanding of the underlying pathophysiology and therapeutic options of polyneuropathies related to COVID-19, which will have an impact on the treatment of the COVID related respiratory failure presenting with neuropathy.
Keywords: Adults; Pediatrics; Polyneuropathies; Post COVID.